Literature DB >> 6240062

Evidence for linkage between the loci coding for the binding protein for the fourth component of human complement (C4BP) and for the C3b/C4b receptor.

S Rodriguez de Cordoba, T R Dykman, F Ginsberg-Fellner, G Ercilla, M Aqua, J P Atkinson, P Rubinstein.   

Abstract

Three pedigrees informative for the segregation of genetic variants of the binding protein for the fourth component of complement (C4BP) and C3b/C4b receptor (C3bR) have been identified. There were 10 informative meioses with no recombinants, indicating a close linkage between the loci encoding C4BP and C3bR, C4BP and C3bR [maximum lod (logarithm of odds of linkage) score: 2.4 at recombinant fraction = 0.0]. In addition, in the four unrelated individuals who were doubly heterozygous (C4BP*1, C4BP*2, C3bR*A, C3bR*B), the infrequent allele C4BP*2 segregated together with the uncommon allele C3bR*B, supporting the hypothesis of linkage between C4BP and C3bR and suggesting that linkage disequilibrium exists between these particular alleles. We conclude that the loci encoding C3bR and C4BP, two functionally related molecules, are linked.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6240062      PMCID: PMC392258          DOI: 10.1073/pnas.81.24.7890

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6.

Authors:  P Teisberg; I Akesson; B Olaisen; T Gedde-Dahl; E Thorsby
Journal:  Nature       Date:  1976-11-18       Impact factor: 49.962

2.  Linkage of HL-A and GBG.

Authors:  F H Allen
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

3.  Inherited structural variation and linkage relationships of C7.

Authors:  M J Hobart; V Joysey; P J Lachmann
Journal:  J Immunogenet       Date:  1978-06

4.  Combined genetic deficiency of C6 and C7 in man.

Authors:  P J Lachmann; M J Hobart; P Woo
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

5.  High resolution isoelectric focusing of immunoprecipitated proteins under denaturing conditions. A simple analytical method applied to the study of complement component polymorphisms.

Authors:  S Rodriguez de Córdoba; P Rubinstein; A Ferreira
Journal:  J Immunol Methods       Date:  1984-04-27       Impact factor: 2.303

6.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

7.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

8.  Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.

Authors:  T Fujita; I Gigli; V Nussenzweig
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

9.  Human C4-binding protein. I. Isolation and characterization.

Authors:  J Scharfstein; A Ferreira; I Gigli; V Nussenzweig
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

10.  The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b.

Authors:  T Fujita; V Nussenzweig
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  10 in total

1.  Coagulation factor XIII B subunit is encoded by a gene linked to the regulator of complement activation (RCA) gene cluster in man.

Authors:  S Rodriguez de Cordoba; J Rey-Campos; D D Dykes; P J McAlpine; P Wong; P Rubinstein
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 2.  CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review.

Authors:  J G Wilson; N A Andriopoulos; D T Fearon
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

3.  Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.

Authors:  Hyon Ju Park; Mara Guariento; Mateusz Maciejewski; Richard Hauhart; Wai-Hong Tham; Alan F Cowman; Christoph Q Schmidt; Haydyn D T Mertens; M Kathryn Liszewski; Dennis E Hourcade; Paul N Barlow; John P Atkinson
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

4.  Large-scale isolation of complement receptor type 1 (CR1) from human erythrocytes. Proteolytic fragmentation studies.

Authors:  R B Sim
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

5.  Does the mouse C4-binding protein gene (C4BP) map in the H-2 region?

Authors:  S Rodríguez de Córdoba; A Ferreira; P Rubinstein
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

6.  The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus.

Authors:  S Van Dyne; V M Holers; D M Lublin; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

7.  The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera.

Authors:  J M Moulds; M W Nickells; J J Moulds; M C Brown; J P Atkinson
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

8.  Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans.

Authors:  J Rey-Campos; P Rubinstein; S Rodriguez de Cordoba
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

9.  A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP.

Authors:  J Rey-Campos; P Rubinstein; S Rodriguez de Cordoba
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

Review 10.  Therapeutic uses of recombinant complement protein inhibitors.

Authors:  K R Kalli; P Hsu; D T Fearon
Journal:  Springer Semin Immunopathol       Date:  1994
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.